EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Memantine as an Adjunctive Treatment for Residual Anxiety and Agitation in Early Parkinson's Disease With Depression: A Case Report

Takaumi Haga, Yuhei Mori iD, Nozomu Matsuda iD, Aya Sato, Yuhei Suzuki iD, Jiro Ono, Itaru Miura iD

Neuropsychopharmacology Reports · 2026-06 · 46 (2)

DOI: 10.1002/npr2.70129 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropsychopharmacology Reports, online erschienen am 13.05.2026. Verfasst von Takaumi Haga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan. Hauptthemen laut MEDLINE: Memantine, Parkinson Disease, Psychomotor Agitation, Anxiety. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non‐motor psychiatric symptoms, including anxiety, agitation, and irritability, are common in Parkinson's disease (PD) and may persist despite antidepressant treatment. While monoaminergic dysfunction has traditionally been emphasized, accumulating evidence suggests that glutamatergic dysregulation, particularly involving N‐methyl‐D‐aspartate (NMDA) receptors, may contribute to these symptoms. However, clinical evidence supporting NMDA receptor modulation in early‐stage PD without dementia remains limited. Case Presentation We report the case of a 65‐year‐old woman with early‐stage PD (Hoehn and Yahr stage I) who developed a severe depressive episode accompanied by prominent anxiety and agitation. Treatment with vortioxetine resulted in partial improvement of depressive symptoms, as reflected by a gradual reduction in the Montgomery–Åsberg Depression Rating Scale score; however, significant anxiety, agitation, and irritability persisted despite adjunctive brexpiprazole, necessitating behavioral restriction. Given the limited response and the clinical characteristics of the residual symptoms, low‐dose memantine (5 mg/day) was introduced as an off‐label adjunctive therapy after obtaining informed consent. Approximately 10 days after memantine initiation, anxiety and agitation markedly improved, allowing discontinuation of behavioral restriction. Motor symptoms and cognitive function remained stable throughout treatment and follow‐up.

Conclusion

This case suggests that NMDA receptor antagonism with low‐dose memantine may be a well‐tolerated adjunctive option for residual anxiety and agitation in early‐stage PD without dementia when conventional antidepressant treatment is insufficient. Although interpretation is limited by the single‐case design and concomitant medications, the findings support further investigation of glutamatergic mechanisms and NMDA receptor modulation in the management of non‐motor psychiatric symptoms in PD .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MemantineParkinson DiseasePsychomotor AgitationAnxietyDepressionExcitatory Amino Acid AntagonistsHumansFemaleAgedAntidepressive AgentsDrug Therapy, Combination

Stichwörter der Autor:innen

Parkinson's diseaseanxietydepressionmemantine

Substanzen

MemantineAntidepressive AgentsExcitatory Amino Acid Antagonists

Autor:innen und Institutionen

  • Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima, Japan.
  • Department of Neurology, School of Medicine, Fukushima Medical University, Fukushima, Japan.

ORCID-Profile: Yuhei Mori, Nozomu Matsuda, Yuhei Suzuki, Itaru Miura

Zitieren

APA

Haga, T., Mori, Y., Matsuda, N., Sato, A., Suzuki, Y., Ono, J., & Miura, I. (2026). Memantine as an Adjunctive Treatment for Residual Anxiety and Agitation in Early Parkinson's Disease With Depression: A Case Report. Neuropsychopharmacology Reports, 46(2). https://doi.org/10.1002/npr2.70129

Vancouver

Haga T, Mori Y, Matsuda N, Sato A, Suzuki Y, Ono J, et al. Memantine as an Adjunctive Treatment for Residual Anxiety and Agitation in Early Parkinson's Disease With Depression: A Case Report. Neuropsychopharmacology Reports. 2026;46(2). doi:10.1002/npr2.70129

BibTeX
@article{Haga2026,
  author = {Haga, Takaumi and Mori, Yuhei and Matsuda, Nozomu and Sato, Aya and Suzuki, Yuhei and Ono, Jiro and Miura, Itaru},
  title = {Memantine as an Adjunctive Treatment for Residual Anxiety and Agitation in Early Parkinson's Disease With Depression: A Case Report},
  journal = {Neuropsychopharmacology Reports},
  year = {2026},
  volume = {46},
  number = {2},
  doi = {10.1002/npr2.70129}
}
Kostenlos starten →